IMMUNIZATION WITH UNIVERSAL INFLUENZA VACCINE ENHANCES IMMUNE RESPONSE TO SUBSEQUENT INFECTION

Código QR

IMMUNIZATION WITH UNIVERSAL INFLUENZA VACCINE ENHANCES IMMUNE RESPONSE TO SUBSEQUENT INFECTION

.

Guardado en:

Detalles Bibliográficos
Autores principales:	M. A. Shuklina, L. A. Stepanova, I. G. Vidyaeva, A. V. Korotkov, E. I. Eletskaya, L. M. Tsybalova
Formato:	article
Lenguaje:	RU
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2018
Materias:	Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/508fabca90ba4936a6017b043b1d3291
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Features of immune response against influenza infection in animals vaccinated with recombinant cross-protective vaccine
por: L. M. Tsybalova, et al.
Publicado: (2019)

OPTIMIZATION OF EXPRESSION, PURIFICATION, AND STABILIZATION CONDITIONS FOR FLG-HA2-4M2E, A RECOMBINANT PROTEIN IN UNIVERSAL INFLUENZA VACCINE
por: A. A. Kovaleva, et al.
Publicado: (2018)

SAPONIN TAUROSID Sx1 ADMINISTRATION ENHANCES ANTIBODY PRODUCTION IN MICE, CHALLENGED WITH INFLUENZA VIRUS OR IMMUNIZED WITH INFLUENZA GRIPPOL® VACCINE
por: V. Yu. Maligina, et al.
Publicado: (2018)

DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR
por: D. A. Mezhenskaia, et al.
Publicado: (2018)

STUDY ON HERD IMMUNITY AGAINST INFLUENZA VIRUS AMONG THE POPULATION OF ALMATY REGION IN 2017–2018
por: A. M. Baimukhametova, et al.
Publicado: (2018)

Intranasal immunization with a recombinant protein based on the M2e peptide and second subunit of influenza A viral hemagglutinin fragment induces a cross-protective humoral and Tcell response in mice
por: M. A Shuklina, et al.
Publicado: (2020)

Humoral immunity, vaccination period and demographic characteristics of first immunized smallpox vaccine recipients
por: O. S. Ermilova, et al.
Publicado: (2021)

THE USE OF CORRELATION ANALYSIS ON THE EXAMPLE OF INFLUENZA VACCINATION ON THE TERRITORY OF THE ROSTOV REGION
por: S. S. Slis’, et al.
Publicado: (2018)

INFLUENCE OF MONOSTRAIN AND MULTISTRAIN AUTOPROBIOTICS ON MICROBIOTA AND IMMUNITY OF RATS WITH INTESTINAL DYSBIOSIS
por: E. Ermolenko, et al.
Publicado: (2018)

COMPARATIVE ESTIMATION OF SENSITIVITY OF SEROLOGICAL REACTIONS FOR ESTIMATION OF IMMUNITY AGAINST THE CAUSATIVE AGENT OF TULAREMIA
por: M. A. Mar’in, et al.
Publicado: (2018)

Formation of humoral and cellular immunity to measles vaccine in adults
por: A. P. Toptygina, et al.
Publicado: (2020)

CONTROL OF INFLUENZA VIA VACCINES: CHALLENGES AND PERSPECTIVES AS VIEWED BY VARIOUS STAKEHOLDERS
por: Y. M. Vasiliev
Publicado: (2018)

GENERATION AND CHARACTERIZATION OF GENETIC REASSORTANTS BETWEEN POTENTIALLY PANDEMIC VIRUSES (A/H9N2 OR A/H5N8) AND THE A/HONG KONG/1/68/162/35 (H3N2) MASTER DONOR VIRUS
por: V. I. Grishchenko, et al.
Publicado: (2018)

CLINICAL TRIAL OF THE PANDEMIC INFLUENZA MONOVALENT VACCINE PANDEFLU
por: M. K. Erofeeva, et al.
Publicado: (2014)

Examining immune arms in mice immunized with site-specific influenza virus mutants
por: S. G. Markushin, et al.
Publicado: (2020)

MYCOBACTERIUM AVIUM-TRIGGERED DISEASE: HOST GENETICS AND IMMUNITY IN MOUSE MODELS
por: I. Linge, et al.
Publicado: (2018)

EPIDEMIC RISE OF INFLUENZA IN ST. PETERSBURG IN JANUARY-MARCH 2018
por: M. A. Bichurina, et al.
Publicado: (2018)

RISK FACTORS FOR SARI AND INFLUENZA VACCINE EFFECTIVENESS IN SENTINEL SURVEILLANCE SYSTEM IN RUSSIA, THE SEASON 2017–2018
por: E. A. Smorodintseva, et al.
Publicado: (2018)

CURRENT APPROACHES TO UNIVERSAL VACCINE AGAINST INFLUENZA VIRUS
por: I. B. Esmagambetov, et al.
Publicado: (2016)

INNATE AND ADAPTIVE IMMUNITY CYTOKINES IN NASAL MUCOSA AND BLOOD SERUM OF ALLERGIC RHINITIS PATIENTS
por: Y. A. Tyurin, et al.
Publicado: (2018)

Immunogenicity and protective efficacy of prime-boost immunization in mice vaccinated with live and inactivated influenza A (H5N1) vaccines
por: I. Losev, et al.
Publicado: (2019)

FEATURES OF POPULATION IMMUNITY AGAINST MEASLES AND RUBELLA VIRUSES. WHY DO ADULTS SUFFER?
por: M. A. Smerdova, et al.
Publicado: (2018)

THE ROLE OF MORAXELLA CATARRHALIS IN THE DEVELOPMENT OF COMPLICATIONS AFTER INFLUENZA AND OTHER ACUTE RESPIRATORY DISEASES
por: L. A. Kraeva, et al.
Publicado: (2018)

THE EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF THE POLYSACCHARIDE PNEUMOCOCCAL VACCINE DURING THE IMMUNIZATION OF HEALTH CARE WORKERS
por: I. V. Feldblum, et al.
Publicado: (2014)

INFLUENCE OF THE NEWCASTLE DISEASE VIRUS ON SOME INDICES OF CELL-MEDIATED IMMUNITY IN TUMOR-BEARING RATS
por: E. Yu. Zlatnik, et al.
Publicado: (2018)

Comparing humoral immune response in adult measles patients and measles vaccinated subjects
por: A. P. Toptygina, et al.
Publicado: (2021)

Do maternal knowledge and attitudes towards childhood immunizations in rural Uganda correlate with complete childhood vaccination?
por: B.J. Vonasek, et al.
Publicado: (2016)

Complex analysis of correlation interrelations between indicators of humoral and cellular immunity in persons vaccinated against plague
por: S. N. Klyueva, et al.
Publicado: (2019)

COMPLIANCE OF ANTHRAX RECOMBINANT VACCINE PROTOTYPE WITH THE REQUIREMENTS TO IMMUNE-BIOLOGICAL PREPARATIONS
por: N. I. Mikshis, et al.
Publicado: (2018)

COMPARISON OF THE PRIMARY AND SECONDARY HUMORAL IMMUNE RESPONSE TO VACCINATION BY “PRIORIX”
por: A. P. Toptygina, et al.
Publicado: (2014)

RESULTS OF MOLECULAR DETECTION AND CHARACTERIZATION OF INFLUENZA AND OTHER RESPIRATORY VIRUSES IN RUSSIA, SEASON 2017–2018
por: A. A. Sominina, et al.
Publicado: (2018)

Immune system parameters in chronic opisthorchiasis patients related to genes polymorphisms associated with developing ischemic heart disease
por: S. A. Grigoryeva, et al.
Publicado: (2021)

MONITORING OF VACCINAL PROCESS IN HUMANS RESIDING IN THE ALTAI HIGH-MOUNTAINOUS NATURAL PLAGUE FOCUS
por: K. M. Korytov, et al.
Publicado: (2018)

STUDY OF IMMUNITY TO POLIOVIRUSES ON CERTAIN "SILENT" TERRITORIES OF RUSSIA
por: N. I. Romanenkova, et al.
Publicado: (2014)

FUNCTIONAL RELEVANCE OF MYCOBACTERIUM TUBERCULOSIS DIVERSITY: FROM GENOTYPES TO IMMUNE RESPONSES AND DISEASE SEVERITY
por: M. Saraiva
Publicado: (2018)

DEVELOPMENT OF A NEW ANTI-INFLUENZA COMPOUND BASED ON CAMPHOR SCAFFOLD
por: V. V. Zarubaev, et al.
Publicado: (2018)

ON THE TIMELINESS OF VACCINATION IN CHILDREN’S OUTPATIENT DEPARTMENT
por: A. A. Golubkova, et al.
Publicado: (2018)

HLA GENE POLYMORPHISM IN PERSONS VACCINATED AGAINST PLAGUE
por: O. M. Kudryavtseva, et al.
Publicado: (2018)

Russian Journal of Infection and Immunity 2014. Special Issue. Theses
por: article Editorial
Publicado: (2015)

SENSITIVITY OF 2018 KAZAKHSTAN INFLUENZA TYPE B VIRUSES TO ANTIVIRAL DRUGS
por: G. V. Lukmanova, et al.
Publicado: (2018)